-=USANA Health Sciences (USNA) reported earnings on Tue 24 Oct 2017 (a/h)

USANA beats by $0.11, reports revs in-line; sees FY17 EPS and revs at high end of previous guidance

• Reports Q3 (Sep) earnings of $1.02 per share, $0.11 better than the two analyst estimate of $0.91; revenues rose 3.0% year/year to $261.77 mln vs the $259.52 mln two analyst estimate.
  • There was no meaningful year-over-year impact from changes in currency exchange rates on quarterly net sales.
  • Also, co's total number of active Customers increased by 2.4% year-over-year to 563,000.
• Co issues in-line guidance for FY17, sees EPS of about $3.70 (from $3.50-3.70) vs. $3.79 two analyst estimate; sees FY17 revs approaching $1.03 bln (from $1.015-1.030 billion) vs. $1.03 bln two analyst estimate.